Pediatric Migraine Clinical Study
Austin Regional Clinic physicians constantly work to improve the care given to all our patients. We are dedicated to offering unique options for our patients and helping them reach their ideal health goals. Part of this dedication involves making clinical research available. Clinical research makes it possible to discover the benefits, risks, and safety of commercially available and investigational medications.
Research standards are very strict to help make studies as safe as possible. Teams of government and research experts have already reviewed each study we conduct to minimize any study risks. Austin Regional Clinic has decided to be involved in this research study because we believe it can potentially benefit our patients.
About the pediatric migraine clinical study
The purpose of the migraine study is to evaluate the safety and effectiveness of an investigational drug. If your child is eligible and you both agree to their participation, your child will take their assigned study drug for one or two separate moderate/severe migraine attacks with moderate/severe headache. Your child’s study drug could be the investigational drug or placebo, which looks like the investigational drug but contains no active medication.
What to expect
We are currently seeking candidates for a clinical research study. During the study, patients can expect:
- Your child’s total study participation may last several weeks or up to 6 months, depending on when the migraine attacks occur. After each migraine attack and dosing, you and your child will return to the study clinic for tests and assessments.
Eligibility criteria
All participants must:
- Be 6-17 years of age
- Have a history of migraines for at least six months
Location
Request to participate
Please contact our ARC Clinical Research team to request to participate by calling 737-247-7240.